Skip to main content
Department of Health Department of Health An Roinn Sláinte Männystrie O Pouste

Main navigation

  • Home
  • Topics
  • Publications
  • Consultations
  • Contact

Translation help

Translate this page

Select a language

  • Arabic — عربي
  • Chinese (Simplified) — 中文简体
  • Chinese (Traditional) — 中文繁體
  • Dutch — Nederlands
  • Filipino — Filipino
  • French — Français
  • German — Deutsch
  • Hungarian — Magyar
  • Irish — Gaeilge
  • Italian — Italiano
  • Latvian — Latviešu
  • Lithuanian — Lietuvių kalba
  • Polish — Polski
  • Portuguese — Português
  • Romanian — Română
  • Russian — Русский
  • Slovak — Slovenčina
  • Spanish — Español
  • Ukrainian — Українська

    • Drug Alerts - 2022

    Topics:
    • Pharmacy, 
    • Regulation of medicines

    Date published: 19 January 2022

    Last updated: 19 December 2022

    Drug alerts issued by DoH during 2022

    Documents

    • PHC 55 2022 - Class 4 Notification - Galderma (U.K.) Limited - Epiduo 0.1% 2.5 % gel (45 g) - PL 10590 0057Adobe PDF (108.33 KB)
    • PHC 54 2022 - Class 4 Notification - Galderma (U.K.) Limited - Etrivex 500 micrograms g Shampoo - PL 10590 0052 (002)Adobe PDF (56.57 KB)
    • PHC 53 2022 - Class 4 Notification - ADVANZ PHARMA T A Mercury Pharmaceuticals Limited - MacroBID 100mg Prolonged-Release Capsules - PL 12762 0052 (002)Adobe PDF (55.9 KB)
    • PHC 52 2022 - Class 4 Notification - Lucis Pharma Ltd - Oxycodone Hydrochloride 10mg ml oral solution- PL 42176 0015Adobe PDF (101.62 KB)
    • PHC 51 2022 - Class 4 Notification - Morningside Healthcare Limited - Hyoscine Butylbromide 20 mg Film-coated Tablets - PL 20117 0349Adobe PDF (53.79 KB)
    • PHC 50 2022 - Class 4 Notification MDR072-10 22 - Venlafaxine XL 300 mg prolonged-release tablets - PL 01883 0363Adobe PDF (40.42 KB)
    • PHC 49 2022 - Class 4 Notification - Macarthys Laboratories (Trading as Martindale Pharma) - Prenoxad (naloxone) 1mg ml Solution ~ PL 12064 0125Adobe PDF (679.79 KB)
    • PHC-48-2022 - Class 3 Medicines Recall -Medreich PLC - Mebeverine hydrochloride 135mg Film-coated Tablets - PL 21880 0247Adobe PDF (98.12 KB)
    • PHC 47 2022 - Medicines Notification - Class 4 Caution in Use - Recordati Rare Diseases - ~ PLGB 15266 0024 and EU 1 04 284 001Adobe PDF (101.73 KB)
    • National Patient Safety Alert - MHRAAdobe PDF (191.69 KB)
    • PHC 46 2022 - Class 1 Medicines Recall - Aventis Pharma Limited t a Sanofi - Targocid 200mg powder for solution for injection ~ PL 04425 0088Adobe PDF (167.84 KB)
    • PHC 45 2022 - Class 2 Medicines Recall - hameln pharma ltd - Ephedrine Hydrochloride 30 mg ml Solution for Injection - PL 01502 0103Adobe PDF (41.94 KB)
    • PHC 44 2022 - Class 4 Notification -Flamingo Pharma UK Ltd - Ibuprofen 400mg Tablets - PL 43461 0005Adobe PDF (398.84 KB)
    • PHC 43 2022 - Class 2 Medicines Recall - hameln pharma ltd -Amiodarone Hydrochloride 50 mg ml Concentrate for Solution for ~ PL 25215 0026Adobe PDF (43.01 KB)
    • PHC 42 2022 - Class 2 Medicines Recall -Aventis Pharma Limited (t a Sanofi) - Stemetil 5mg 5ml SyrupAdobe PDF (102.08 KB)
    • PHC 41 2022 - Class 2 Medicines Recall , Novartis Pharmaceuticals UK, Sandimmun Oral SolutionAdobe PDF (64.95 KB)
    • PHC 40 2022 - 4mg ml Oral Suspension PL 00427 0256 and Sildenafil 10mg ml Oral Suspension PL 00427 0258Adobe PDF (29.31 KB)
    • PHC 39 2022 - Class 4 Notification - Quadrant Pharmaceuticals Limited, Bezalip Mono 400mg TabletsAdobe PDF (43.44 KB)
    • PHC 38 2022 - Class 2 Medicines Recall - Hikma Pharmaceuticals USA Inc - Lorazepam InjectionAdobe PDF (142.37 KB)
    • PHC 37 2022 - Class 2 Medicines Recall - Ipsen Limited, Dysport 500 Units Powder for Solution for Injection - PL 34926 0001Adobe PDF (40.19 KB)
    • PHC 36 2022 - Class 4 - Medicines Notification - Accord Healthcare Limited, Rosuvastatin 5, 10, 20 mg film-coated tabletsAdobe PDF (33.25 KB)
    • PHC 35 2022 - Class 2 - Medicines Recall - Sun Pharmaceutical Industries Europe BV - Zoledronic acid SUN 5mg solution for infusionAdobe PDF (41.51 KB)
    • PHC 34 2022 - Class 1 - Medicines Recall - Patient, Pharmacy, Wholesaler Level Recall - Clinigen ~ Mexiletine hydrochloride Hard CapsulesAdobe PDF (327.51 KB)
    • PHC 33 2022 Class 4 medicines defect information - Novo - NovoRapid and Saxenda FlexTouch pensAdobe PDF (208.72 KB)
    • PHC-32-2022 Class 4 medicines defect information - Omega Pharma Limited - Niquitin 14mg Clear Patch - PL 02855 0251Adobe PDF (219.18 KB)
    • PHC-31-2022 - Class 2 Medicines Recall - hameln pharma ltd - Amiodarone Hydrochloride 50 mg ml Concentrate forAdobe PDF (40.46 KB)
    • PHC-30-2022 -Class 4 Medicines Defect Information - Thornton Ross -Covonia (P)Adobe PDF (141.07 KB)
    • PHC-29-2022 - Class 4 medicines defect information - Phenylephrine 0.08 mg ml - solution for injection infusionAdobe PDF (52.45 KB)
    • PHC-28-2022 - Class 2 Medicines Recall - Phenobarbital 60 mg TabletsAdobe PDF (154.37 KB)
    • PHC-27-2022 - CLass 4 Medicines Notification - Napp Pharmaceuticals Limited - OxyContin 20 mg prolonged release tablets - PL 16950 0098Adobe PDF (148.43 KB)
    • PHC-26-2022 - CLass 4 Medicines Notification - DEMO SA Pharmaceutical Industry - Esomeprazole 40mg PowderAdobe PDF (40.07 KB)
    • PHC-25-2022- Class 4 Medicines Notification - Orifarm UK Ltd - Loprazolam 1mg Tablets - PLPI 46927 0262 (002)Adobe PDF (137.57 KB)
    • PHC-24-2022 - Class 2 Medicines Recall - hameln pharma ltd - Water for Injections BP 100ml vial - PL 01502 0003RAdobe PDF (139.68 KB)
    • PHC-23-2022 - Class 2 Medicines Recall - Mefenamic Acid 500mg film coated tabletsAdobe PDF (227.41 KB)
    • PHC-22-2022- Class 4 Medicines Notification - GlaxoSmithKline UK Ltd - Zovirax I.V. 500 mg - PL 00003 0159 - Updated 24 May 2022Adobe PDF (258.87 KB)
    • PHC-21-2022 - Class 2 Medicines Recall - Pfizer Limited - Accupro - film-coated tabletsAdobe PDF (45.86 KB)
    • PHC-20-2022 - Class 2 Medicines Recall - Fresenius Kabi Limited Sodium bicarbonate 1.26% Solution for infusion PL 08828 0013Adobe PDF (153.19 KB)
    • PHC-19-2022 - Class 2 Medicines Recall - Crescent Pharma Limited - Paroxetine 40mg Film Coated TabletsAdobe PDF (152.08 KB)
    • PHC-18-2022 - Pfizer Limited - Depo-Medrone with Lidocaine 40 mg mL (1 mL and 2 mL vials-single vial preparations) - PL 00057 0964Adobe PDF (164.48 KB)
    • PHC-17-2022 - Class 2 Medicines Recall - USV UK Limited - Olopatadine USV 1mg mL eye drops, solution - PL 32870 0055Adobe PDF (28.83 KB)
    • PHC-16-2022 - Medicines Recall - Class 2 Medicines Recall - Pfizer Limited - Accuretic 10 12.5 mg film-coatedAdobe PDF (138.32 KB)
    • PHC-15-2022- Class 4 Medicines - Benzylpenicillin benzathine Million I.U. powder and solvent for suspension for injectionAdobe PDF (145.99 KB)
    • PHC-14-2022- Class 4 Medicines Notification - Ayrton Saunders Limited - Hayfever Allergy Relief Nasal Spray (002)Adobe PDF (161.14 KB)
    • PHC-13-2022- Class 4 Medicines Notification - CNX Therapeutics Ltd - Latuda film-coated tabletsAdobe PDF (44.92 KB)
    • PHC-12-2022- Class 4 Medicines Notification - Boots Company Plc - Decongestant TabletsAdobe PDF (297.45 KB)
    • PHC-11-2022 - Class 2 Medicines Recall - Wockhardt UK Ltd - Diazepam RecTubes 2.5mg Rectal SolutionAdobe PDF (139.27 KB)
    • PHC-10-2022 - Class 3 Medicines Recall - Kyowa Kirin Services Ltd - Isotard 60mg XL Tablets - PL 16508 0022Adobe PDF (139.86 KB)
    • PHC-9-2022- Class 4 Medicines Notification - Atnahs Pharma UK Limited - Naprosyn TabletsAdobe PDF (74.19 KB)
    • PHC-8-2022 - Class 2 Medicines Recall - medac GmbH (t a medac Pharma LLP) - Fluorouracil Injection 50 mg ml solution forAdobe PDF (139.35 KB)
    • PHC-7-2022 - Class 2 Medicines Recall - Uni Health Distribution - Efudix 5% w w cream Adobe PDF (140.71 KB)
    • PHC-6-2022 - Class 2 Recall - hameln pharma ltd - Water for Injections BP 100ml vialAdobe PDF (227.69 KB)
    • PHC-5-2022 - Class 4 Medicines Notification - Atnahs Pharma UK Limited - Naprosyn TabletsAdobe PDF (74.36 KB)
    • PHC 4 2022 - Class 4 Medicines Notification - Flamingo Pharma UK Ltd - Ibuprofen 400mg TabletsAdobe PDF (38.3 KB)
    • PHC 3 2022 - Class 4 Medicines Defect - Antibiotice SA - Piperacillin Tazobactam 4 g 0.5g Powder for solution for infusionAdobe PDF (44.47 KB)
    • PHC 2 2022 - Class 4 Medicines Defect - Fresenius Kabi Limited - Kabiven Emulsion for Infusion - PL 08828 0131Adobe PDF (183.83 KB)
    • PHC 1 2022 - Class 2 Medicines Recall - Santen Oy (trading as Santen UK Limited) - Ikervis 1 mg ml eye drops, emulsion(3)Adobe PDF (142.33 KB)
    Share this page Share on Facebook (external link opens in a new window / tab) Share on X (external link opens in a new window / tab) Share by email (external link opens in a new window / tab)

    Department footer links

    • Crown copyright
    • Terms and Conditions
    • Privacy
    • Cookies
    • Accessibility
    • The Northern Ireland Executive
    • The Executive Office
    • Department of Agriculture, Environment and Rural Affairs
    • Department for Communities
    • Department for Education
    • Department for the Economy
    • Department of Finance
    • Department for Infrastructure
    • Department for Health
    • Department of Justice
    • nidirect.gov.uk — the official government website for Northern Ireland citizens